To download the full report, click here.

There are proposals popping up nationwide that would require pharmaceutical manufacturers to submit reports to the government, public and private insurers, and pharmacy benefit managers (PBMs) relaying increases in the list price of a medicine prior to the price increase taking effect. While these proposals purport to be a way to lower prescription drug prices, the actual impact of advance price notifications could have serious unintended consequences.